Oscillating Positive Expiratory Pressure Devices Market Global Report 2028
진동식 호기압(OPEP) 장치 시장은 2021년 1억 2,566만 달러에서 2028년 1억 7,934만 달러로 성장할 것으로 예상됩니다. 2021~2028년에는 연평균 성장률(CAGR) 5.2%로 성장할 것으로 예상됩니다.
진동성 호기압(OPEP) 장치는 기침을 할 수 없는 사람, 특히 만성 질환이 있는 사람의 호흡기 분비물을 제거하는 데 도움이 되는 전통적인 흉부 물리 치료(CPT)의 보조 장치로 사용되어 왔습니다. OPEP 장치의 사용은 낭포성 섬유증, 기관지 확장증, 기관지염, 기관지 천식 및 원발성 섬모 운동이상 증후군과 같은 만성 기도 장애에서 여전히 제한적입니다. 만성 폐쇄성 폐질환(COPD)의 경우 진동 호기 양압(OPEP) 장치가 가래 제거에 도움이 됩니다.
진동식 호기압(OPEP) 장치 시장 성장은 만성 폐쇄성 폐질환(COPD) 및 천식의 확산과 의료 기술의 발전에 기인합니다. 그러나 낮은 인식과 OPEP 장치에 대한 제한된 접근은 시장 성장을 방해합니다.
귀하의 요구 사항에 맞게 연구를 맞춤화하십시오
우리는 표준 제품을 통해 충족되지 않는 분석과 범위를 최적화하고 조정할 수 있습니다. 이러한 유연성은 비즈니스 계획 및 의사 결정에 필요한 정확한 정보를 얻는 데 도움이 됩니다.
진동 호기압(OPEP) 장치 시장:
Oscillating Positive Expiratory Pressure (OPEP) Devices Market: Strategic Insights
Oscillating Positive Expiratory Pressure (OPEP) Devices Market
-
CAGR (2021 - 2028)
5.2%
-
Market Size 2021
US$ 125.66 Million
-
Market Size 2028
US$ 179.34 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Allergan Plc
- PARI GmbH
- Smiths Medical
- AirPhysio
- D R BURTON HEALTHCARE
- Medica Holdings LLC
- CEGLA Medizintechnik GmbH Co KG
- Able Healthcare
- Trudell Medical International
Regional Overview
- 북미
- 유럽
- 아시아 태평양
- 중남미
- 중동 및 아프리카
Market Segmentation
제품
- 마우스피스 PEP 장치
- 안면 마스크 PEP 장치 및 병 PEP 장치
적응증
- 만성폐쇄성폐질환
천식, 기관지염, 기관지확장증, 낭성섬유증 등)
유통채널
- 병원약국
- 온라인약국
- 소매약국
Oscillating Positive Expiratory Pressure (OPEP) Devices Market: Strategic Insights
-
CAGR (2021 - 2028)5.2% -
Market Size 2021
US$ 125.66 Million -
Market Size 2028
US$ 179.34 Million
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Allergan Plc
- PARI GmbH
- Smiths Medical
- AirPhysio
- D R BURTON HEALTHCARE
- Medica Holdings LLC
- CEGLA Medizintechnik GmbH Co KG
- Able Healthcare
- Trudell Medical International
Regional Overview
- 북미
- 유럽
- 아시아 태평양
- 중남미
- 중동 및 아프리카
Market Segmentation
- 마우스피스 PEP 장치
- 안면 마스크 PEP 장치 및 병 PEP 장치
- 만성폐쇄성폐질환
- 병원약국
- 온라인약국
- 소매약국
CAGR(2021~2028)5.2%- 시장 규모 2021년
US$ 1억 2,566만 - 시장 규모 2028
US$ 1억 7934만
시장 역학
- XXXXXX
- XXXXXX
- XXXXXX
- XXXXXX
- XXXXXX
- XXXXXX
- XXXXXX
- XXXXXX
- XXXXXX
주요 선수
- Allergan Plc.
- 파리 GmbH
- 스미스 메디컬
- 에어피지오
- D?R 버튼 헬스케어
- 메디카 홀딩스, LLC
- CEGLA Medizintechnik GmbH & Co. KG
- 에이블헬스케어
- 트루델 메디컬 인터내셔널
지역 개요
- 북아메리카
- 유럽
- 아시아 태평양
- 남미 및 중미
- 중동 및 아프리카
시장 세분화
- 마우스피스 PEP 장치
- 페이스 마스크 PEP 장치
- 병 PEP 장치
- 만성 폐쇄성 폐질환
- 병원 약국
- 온라인 약국
- 소매 약국
- 샘플 PDF는 정성적, 정량적 분석을 통해 콘텐츠 구조와 정보의 성격을 보여줍니다.
시장 통찰
만성 폐쇄성 폐질환(COPD) 및 천식의 확산으로 시장 성장 촉진
COPD와 낭포성 섬유증의 발병률은 전 세계적으로 증가하고 있습니다. 세계보건기구(WHO)에 따르면 COPD 악화는 중요한 사건입니다. COPD 관련 장애 및 사망률은 OPEP 장치에 대한 수요를 촉진합니다. 질병 통제 예방 센터(CDC)에 따르면 2018년에 약 900만 명의 성인이 만성 기관지염 진단을 받았습니다 . 또한 천식은 모든 연령, 성별, 인종의 사람들에게 일반화되고 있습니다. CDC에 따르면 전 세계적으로 약 3억 명이 천식을 앓고 있으며 2025년까지 1억 명이 추가될 것으로 예상됩니다. 천식의 유병률, 중증도 및 사망률은 미국 전역에서 크게 다릅니다. 천식은 미국 내 2,500만 명 이상의 사람들에게 영향을 미치며 이는 성인의 7.7%, 어린이의 8.4%에 해당합니다. 뉴질랜드 오클랜드에 관한 2018년 글로벌 천식 보고서에 따르면, 천식은 장애 조정 수명 기준으로 평가할 때 장애의 가장 큰 원인 중 16위, 질병 부담의 가장 큰 원인 중 28위를 차지합니다. 이는 고소득 국가에서 흔히 발생하는 반면, 천식 관련 사망의 대부분은 저소득 및 중간 소득 국가에서 발생합니다. 따라서 COPD 및 천식의 유병률 증가로 인해 OPEP 장치와 같은 점액 제거 장치에 대한 수요가 증가하여 OPEP(진동 호기압) 장치 시장의 성장이 강화됩니다.
제품 기반 통찰력
진동 양압(OPEP) 장치 시장은 제품을 기준으로 마우스피스 PEP 장치, 안면 마스크 PEP 장치 및 병 PEP 장치로 분류됩니다. 마우스피스 PEP 장치 부문은 2021년 시장에서 가장 큰 점유율을 차지했습니다. 또한 예측 기간 동안 시장에서 5.3%의 CAGR을 기록할 것으로 예상됩니다. 마우스피스 PEP는 폐에서 점액을 제거하는 데 도움이 됩니다. 또한 폐 허탈을 예방하거나 허탈된 부위를 열 수 있습니다. 마우스피스 PEP 장치 시장을 이끄는 주요 요인 중 하나는 노인 인구 증가와 만성 폐쇄성 폐질환(COPD) 및 천식과 같은 만성 질환 발병률의 증가입니다. 질병 통제 예방 센터(CDC)에 따르면 2020년까지 약 900만 명이 만성 기관지염 진단을 받을 것이며, 이에 따라 마우스피스 장치에 대한 필요성이 높아질 것입니다.
표시 통찰력
적응증에 따라 진동하는 호기압(OPEP) 장치 시장은 만성 폐쇄성 폐질환(COPD), 천식, 기관지염, 기관지 확장증, 낭포성 섬유증 등으로 분류됩니다. COPD 부문은 2021년 시장에서 가장 큰 점유율을 차지했습니다. 그러나 천식 부문은 예측 기간 동안 6.0%의 CAGR을 기록할 것으로 예상됩니다. COPD는 점진적인 기류 제한과 조직 파괴를 특징으로 하는 흔하고 치료 가능한 질병입니다. 이는 유해 입자나 가스(가장 일반적으로 담배 연기)에 장기간 노출되어 발생하는 만성 염증으로 인한 폐의 구조적 변화와 관련이 있습니다. 만성 염증은 기도를 좁히고 폐 반동을 감소시킵니다.
제품 출시 및 승인은 기업이 글로벌 입지와 제품 포트폴리오를 확장하기 위해 일반적으로 채택하는 전략입니다. 또한 OPEP(진동 호기압) 장치 시장 참여자들은 고객층을 확대하기 위한 파트너십 전략에 중점을 두고 있으며, 이를 통해 전 세계적으로 브랜드 이름을 유지할 수 있습니다. 시장 참가자들의 혁신적인 제품 개발로 인해 향후 몇 년 동안 시장이 번성할 것으로 예상됩니다.
진동 호기 양압 장치 시장 보고서 범위
보고서 속성 | 세부 |
---|---|
2021년 시장규모 | 미화 1억 2,566만 달러 |
2028년까지 시장 규모 | 1억 7,934만 달러 |
글로벌 CAGR(2021~2028) | 5.2% |
과거 데이터 | 2019-2020 |
예측기간 | 2022년부터 2028년까지 |
해당 세그먼트 | 제품별
|
해당 지역 및 국가 | 북아메리카
|
시장 리더 및 주요 회사 프로필 |
|
- 샘플 PDF는 정성적, 정량적 분석을 통해 콘텐츠 구조와 정보의 성격을 보여줍니다.
회사 프로필
- Allergan Plc.
- 파리 GmbH
- 스미스메디컬
- 에어피지오
- D•R 버튼 헬스케어
- 메디카 홀딩스, LLC
- CEGLA Medizintechnik GmbH & Co. KG
- 에이블헬스케어
- 트루델 메디컬 인터내셔널
- 머큐리 메디컬
Oscillating Positive Expiratory Pressure (OPEP) Devices Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 125.66 Million |
Market Size by | US$ 179.34 Million |
Global CAGR | 5.2% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 제품
|
Regions and Countries Covered |
북미
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
COVID-19 was more likely to hospitalize those with moderate-to-severe or uncontrolled asthma. The coronavirus can cause pneumonia, blood clots, and acute respiratory distress syndrome, among other lung issues. The epidemic has added new levels of anxiety for both patients and clinicians for the nearly 37 million Americans who live with a chronic lung illness like asthma or chronic obstructive pulmonary disease. Caring for people with COVID-19 and underlying COPD is very difficult at this time. Certain treatments for COPD patients, such as nebulized bronchodilators and non-invasive ventilation (NIV), are thought to enhance the risk of viral transmission via aerosols. Although oscillating positive expiratory pressure (OPEP) devices have been in use with the increasing cases of COVID-19 in the region as studies shows oscillating positive expiratory pressure (OPEP) devices results in minimizing the effect of respiratory distress due to COVID. Also, the Positive Expiratory Pressure (PEP) flute therapy and Positive End-Expiratory Pressure (PEEP) proved to be led to a small yet statistically significant decrease in the severity of respiratory symptoms in adults with COVID-19 recovering at home as per various research studies.
North America held the largest share of the oscillating positive expiratory pressure (OPEP) devices market and is expected to continue its position over the coming years. These oscillating positive expiratory pressure (OPEP) devices are in high demand in North America's regional segment. Furthermore, the presence of a robust medical infrastructure and the early availability of new products and equipment are aiding the area market's overall development.
Trudell Medical International and Allergan Plc are the top two companies that hold huge market shares in the Oscillating Positive Expiratory Pressure (OPEP) Devices market.
The Oscillating Positive Expiratory Pressure (OPEP) Devices market majorly consists of players such as Allergan Plc.; PARI GmbH; Smiths Medical; AirPhysio; D•R BURTON HEALTHCARE; Medica Holdings, LLC; CEGLA Medizintechnik GmbH & Co. KG; Able Healthcare; Trudell Medical International; Mercury Medical amongst others.
The hospital pharmacies segment dominated the global oscillating positive expiratory pressure (OPEP) devices market and accounted for the largest market share of 60.48% in 2021.
The mouthpiece PEP devices segment held the largest share of the market in the global oscillating positive expiratory pressure (OPEP) devices market and held the largest market share of 94.68% in 2021.
The chronic obstructive pulmonary disease (COPD) segment dominated the global oscillating positive expiratory pressure (OPEP) devices market and accounted for the largest market share of 34.60% in 2021.
Oscillatory positive expiratory pressure (OPEP) devices have been used as a supplement to traditional chest physiotherapy (CPT) to aid in the clearing of respiratory secretions in people who can't cough, especially those with chronic conditions. In chronic airway disorders such as cystic fibrosis, bronchiectasis, bronchitis, bronchial asthma, and primary ciliary dyskinesia syndrome, the usage of OPEP devices is still limited. In chronic obstructive pulmonary disease (COPD), oscillating positive expiratory pressure (OPEP) devices are said to help with sputum clearance.
Key factors that are driving the growth of this market are the growing prevalence of chronic obstructive pulmonary disease (COPD) and asthma, and rising technological advancements are expected to boost the market growth for oscillating positive expiratory pressure (OPEP) devices over the years.
The CAGR value of the oscillating positive expiratory pressure (OPEP) devices market during the forecasted period of 2021–2028 is 5.2%.
The List of Companies - Oscillating Positive Expiratory Pressure (OPEP) Devices Market
- Allergan Plc.
- PARI GmbH
- Smiths Medical
- AirPhysio
- D•R BURTON HEALTHCARE
- Medica Holdings, LLC
- CEGLA Medizintechnik GmbH & Co. KG
- Able Healthcare
- Trudell Medical International
- Mercury Medical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.